Trial Profile
Sorafenib With or Without Transarterial Chemoembolization (TACE) in Advanced Hepatocellular Carcinoma : A Multicenter, Randomized, Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Doxorubicin; Ethiodized oil; Polyvinyl alcohol
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms SELECT
- 31 Jul 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 31 Jul 2019 Planned primary completion date changed from 1 Sep 2018 to 1 Sep 2020.
- 20 Mar 2018 Planned End Date changed from 1 Jun 2016 to 1 Dec 2018.